William Vainchencker

Title: William Vainchencker: Innovator in Glycoprotein Research

Introduction

William Vainchencker is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the area of glycoproteins. His work has implications for understanding platelet functions and their interactions with collagen.

Latest Patents

William Vainchencker holds a patent for "Glycoprotein VI antibodies and uses thereof." This invention provides isolated nucleic acid molecules and polypeptide molecules that encode glycoprotein VI, a platelet membrane glycoprotein involved in platelet-collagen interactions. The patent also includes antisense nucleic acid molecules, expression vectors containing the nucleic acid molecules, host cells with introduced vectors, and non-human transgenic animals with introduced or disrupted nucleic acid molecules. Additionally, the invention encompasses isolated polypeptides, fusion polypeptides, antigenic peptides, and antibodies. Diagnostic, screening, and therapeutic methods utilizing these compositions are also part of the patent.

Career Highlights

William Vainchencker is associated with Millennium Pharmaceuticals Limited, where he has been instrumental in advancing research related to glycoproteins. His innovative work has contributed to the understanding of platelet biology and potential therapeutic applications.

Collaborations

Throughout his career, William has collaborated with esteemed colleagues such as Samatha J. Busfield and Jean-Luc Villeval. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

William Vainchencker is a prominent figure in the field of glycoprotein research, with a patent that holds promise for therapeutic advancements. His contributions continue to influence the biotechnology landscape.